Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 American Medical Holdings Develops FB3 Fusion Ingredient Beverage - Nutraceuticals World

What are you searching for?

Sign in
Products & Ingredients

American Medical Holdings Develops FB3 Fusion Ingredient Beverage

By: Lisa Olivo

, Rodman Media

American Medical Holdings, New York, NY, in association with Japan Bioactives has launched FB3 Fusion Ingredient Beverage for the weight management category.
 
“In addition to our FB3 tablets, the interest in foods and beverages containing healthy ingredients has led to development of FB3 Fusion Ingredient in form of on-the-go shot drink with pomegranate in a 50 ml serving size,” says Vladimir Badmaev, MD, PhD, CEO of American Medical Holdings and product inventor.   
 
He added, “The objective for the FB3 beverage development has been to deliver more ‘fun’ to the consumer but with the solid and continuous science supported functionality. The ultimate goal has been to develop a product with good compliance and outstanding and proven quality in maintaining healthy weight. Versatility in product delivery is highly attractive to many consumers who may not want to constantly swallow pills or who cannot.”  
 
FB3 Fusion Ingredient is an herbal composition of Coleus forskohlii, Salacia reticulata, and Sesamum indicum, standardized for forskolin, salacinol, and sesamin, respectively. The ingredient was shown, in vitro, to inhibit pancreatic lipase with differing degrees and dynamics. The published study demonstrated that the formula’s botanicals synergistically prevented absorption of excess dietary fat (n-6 fatty acids are typically abundant in the Western diet). Hypothetically, preventing absorption of excess dietary fat and n-6 fatty acids may gradually normalize the overactive endocannabinoid system, thereby preventing obesity, especially if this approach is combined with consuming an n-3 fatty acids-rich diet, which competes with n-6 fatty acid absorption.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics